节点文献

乳腺良、恶性病变Ki67单克隆抗体标记观察

Study of Ki67 Immunostaining in Benign and Malignant Breast Lesions

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张树华吴照敏李保文郑国均

【Author】 Zhang Shuhua , Wu Zhaomin, Li Baowen et al (Dept of Pathol, Binzhou Medical College, Shandong 256603)

【机构】 滨州医学院病理学教研室滨州医学院病理学教研室 山东 256603山东 256603山东 256603

【摘要】 本文用Ki67单克隆抗体对11例乳腺浸润性导管癌、10例乳腺良性病变做了研究。结果显示乳癌Ki67标记阳性率较高(M 12.5),良性病变较低(M 8.15),两者间差异有显著性(P=0.05)。乳癌Ki67标记阳性率与核分裂计数和核面积呈显著正相关(相关系数分别为0.849,P<0.01和0.740,P<0.01)。未发现与淋巴结转移、肿物大小和年龄之间的相关性(P>0.05)。

【Abstract】 Eleven cases of infiltrating duct carcinoma of breast and 10 cases of benignbreast lesions were studied by immuostain-ing with monoclonal antibody Ki67. The re- suits showed that Ki67 labeling rates of breast carcinoma were higher ( Median 12-5), benign lesions lower (Median 8- 15) , there was a significant difference between them (P = 0. 05). The Ki67 labeling rates of breast carcinoma were related to mitotic count and nuclear area (r=0. 849,P <0. 01; r=0. 740, P<0. 01 respectively).There was not relation-ship between Ki67 labeling rates of breast carcinoma, lymph node involvement, tumor in diameter, and age (P>0. 05).

  • 【文献出处】 临床与实验病理学杂志 ,Chinese Journal of Clinical and Experimental Pathology , 编辑部邮箱 ,1994年04期
  • 【分类号】R737.9
  • 【被引频次】6
  • 【下载频次】51
节点文献中: 

本文链接的文献网络图示:

本文的引文网络